Pii Fills Key Leadership Position with New Vice President of Business Development

HUNT VALLEY, Md., Nov. 13, 2018 /PRNewswire/ -- Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) headquartered in Hunt Valley, Maryland, announced today that it has filled a key leadership position with the appointment of Hank Nowak, Vice President of Business Development.  Mr. Nowak joins Pii with nearly 30 years of experience in the pharmaceutical industry, most recently serving as the Head of Global Business Development at Metabolon, Inc., a leading provider of metabolomics services.  Prior to Metabolon, Hank held Business Development leadership positions with Banner Pharmacaps, DSM Pharmaceuticals and Patheon Manufacturing Services, Inc., having begun his career as a research scientist with Bristol-Myers Squibb.

Mr. Nowak commented, "I'm both honored and excited to join Pii, an organization with a legacy of success, in developing and manufacturing pharmaceutical products for a range of partners.  Collaborating with a seasoned leadership team, a staff of highly-skilled scientists, operators and subject matter experts, I look forward to driving the commercial strategy and ensuring Pii continues to deliver valued solutions to the biopharmaceutical industry."

Mr. Michael Bogda, President and Chief Operating Officer commented, "We are excited to welcome Hank to our leadership team and look forward to working with him as we continue to execute our growth strategy.  Hank's prior experience across a diverse line of service offerings will complement our seasoned business development team and will help to accelerate our expansion efforts."

About Pharmaceutics International, Inc.

Pii is a privately held CDMO providing dosage form development and cGMP manufacturing services to the global pharmaceutical industry. Headquartered in Hunt Valley, Maryland USA, Pii's services include pre-formulation development, and clinical and commercial cGMP manufacturing of parenterals, liquid solutions and oral solids, including soft gels, tablets and capsules. In addition, the Company offers containment suites to handle potent drugs and Schedules I-V controlled substances.  For more information, please visit www.pharm-int.com.

Contact:
Syed E. Abidi, Ph.D., Chairman and CEO
Pharmaceutics International, Inc.
10819 Gilroy Road
Hunt Valley, MD 21031
Phone: (410) 584-0001
Email:  [email protected]

SOURCE Pharmaceutics International, Inc.

Related Links

http://www.pharm-int.com